𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia

✍ Scribed by Siegfried Kasper; Anthony Hale; Jean-Michel Azorin; Hans-Jürgen Müller

Publisher
Springer-Verlag
Year
1999
Tongue
English
Weight
343 KB
Volume
249
Category
Article
ISSN
1433-8491

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neurocognition and its influencing facto
Neurocognition and its influencing factors in the treatment of schizophrenia—effects of aripiprazole, olanzapine, quetiapine and risperidone
✍ M. Riedel; R. Schennach-Wolff; R. Musil; S. Dehning; A. Cerovecki; M. Opgen-Rhei 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 2 views

## Abstract ## Background To examine influencing variables of neurocognition in patients with schizophrenia and to predict cognition during antipsychotic treatment. ## Methods Data were obtained from patients with an acute episode of schizophrenia participating in two double‐blind and one open l

Risperidone versus olanzapine for the tr
Risperidone versus olanzapine for the treatment of delirium
✍ Sung-Wan Kim; Joon-An Yoo; Sam-Yeon Lee; Seon-Young Kim; Kyung-Yeol Bae; Su-Jin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Abstract ## Objective This study compared the effectiveness of risperidone and olanzapine in the treatment of delirium. ## Methods This was a 7‐day, randomized, comparative clinical trial of risperidone and olanzapine in patients with delirium. The primary outcome measure was the Delirium Rat